The GLP-1s that were originally marketed as a diabetes treatment include semaglutide, brand name Ozempic, liraglutide, brand name Victoza, dulaglutide, brand name Trulicity, and the latest GLP-1 to the market, tirzepitide, brand name Mounjaro, which is a combination GIP/GLP-1
(4) The PI3K/Akt pathway, inhibited by GLP-1R in the TNC, was proven to participate in the development of CM
It also includes GLP-1 companion products used during care
For context on peptides relevant to metabolic research applications, explore our peptides for gut health research guide
It also reduces inflammation and improves insulin sensitivity, enhancing the bodys response to insulin, promoting glucose uptake into cells, as well as reducing the risk of associated metabolic complications